Besides this, other factors like the use of ACE inhibitors blocking the renin–angiotensin–aldosterone system have been found associated to a reduced mortality in COVID-19 patients54, although in our study the proportion of patients with these medications was not different between the study groups. The gene discussed is ACE; the disease is COVID-19.